The first phase of the study, “The feasibility of collecting, processing and storing COVID-19 convalescent plasma for treatment of COVID-19 in Uganda” was kicked off.
The aim of the feasibility is to collect and process COVID-19 convalescent plasma for treatment of COVID-19.
Convalescent plasma is plasma from individuals who have recovered from an infection, and this plasma may contain antibodies against that infection.
The study was conducted by the COVIDRES-Uganda Research group; a multi-disciplinary research group coordinated by the Makerere University Lung Institute (MLI).
The research group/ collaborators on this study included members from MLI, Uganda Peoples Defence Forces Medical Services, Mulago National Referral Hospital, Uganda Cancer Institute among others.
Giving her remarks, Hon .Dr. Jane Aceng Ocero, Minister of Health said Covid-19 has no treatment. “What is given currently is only support. So having convalescent plasma come on board is great and we are looking forward to it being started tomorrow”.
According to Hon. Aceng, Uganda is losing 2-3 covid-19 patients per day and the numbers are climbing up every day thus the need for more innovations.
Uganda has reported more than 5,000 cases of the virus and 58 deaths.
She cautioned Ugandans “It is with us. Do not to become part of the statistics but part of those that are supporting the response to ensure that Ugandans remain alive”